Your browser doesn't support javascript.
loading
Magnetic Resonance Imaging-Transrectal Ultrasound Guided Fusion Biopsy to Detect Progression in Patients with Existing Lesions on Active Surveillance for Low and Intermediate Risk Prostate Cancer.
Frye, Thomas P; George, Arvin K; Kilchevsky, Amichai; Maruf, Mahir; Siddiqui, M Minhaj; Kongnyuy, Michael; Muthigi, Akhil; Han, Hui; Parnes, Howard L; Merino, Maria; Choyke, Peter L; Turkbey, Baris; Wood, Brad; Pinto, Peter A.
Affiliation
  • Frye TP; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • George AK; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Kilchevsky A; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Maruf M; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Siddiqui MM; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Kongnyuy M; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Muthigi A; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Han H; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Parnes HL; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Merino M; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Choyke PL; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Turkbey B; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Wood B; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
  • Pinto PA; Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical P
J Urol ; 197(3 Pt 1): 640-646, 2017 03.
Article in En | MEDLINE | ID: mdl-27613356
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Population Surveillance / Ultrasonography, Interventional / Magnetic Resonance Imaging, Interventional / Image-Guided Biopsy Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Population Surveillance / Ultrasonography, Interventional / Magnetic Resonance Imaging, Interventional / Image-Guided Biopsy Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2017 Type: Article